albendazole has been researched along with Co-infection in 16 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prevalence of lymphatic filariasis in adults above 18 years was 42." | 5.43 | Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania. ( Clowes, P; Haule, A; Hoelscher, M; Hoerauf, A; Kowuor, D; Kroidl, I; Löscher, T; Maboko, L; Mabuye, J; Maganga, L; Makunde, WH; Malecela, MN; Mgeni, N; Mviombo, P; Mwingira, U; Pitter, B; Saathof, E, 2016) |
| " No serious adverse events occurred, and the majority of adverse events were mild in intensity (mainly headache, abdominal pain, diarrhoea and "other signs/symptoms")." | 2.78 | A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali. ( Coulibaly, YI; Daou, A; Dicko, I; Doumbia, M; Haidara, FC; Horton, J; Keita, M; Keita, MM; Sankare, MH; Sow, SO; Whately-Smith, C, 2013) |
| "Here we report coinfection of pulmonary hydatid cyst and aspergilloma in a 34-year-old female who had had history of minor thalassemia and suffered from chest pain, dyspnea, non-productive cough for at least five months, and hemoptysis for 20 days." | 2.53 | Coinfection of Pulmonary Hydatid Cyst and Aspergilloma: Case Report and Systematic Review. ( Aliyali, M; Badali, H; Dolatabadi, S; Godazandeh, G; Moazeni, M; Nabili, M; Nosrati, A; Shokohi, T, 2016) |
| " However, there are no published data regarding adverse events associated with these medications." | 1.56 | Schistosomiasis and soil-transmitted helminthiasis preventive chemotherapy: Adverse events in children from 2 to 15 years in Bengo province, Angola. ( Barros, H; Brito, M; Fançony, C; Lemos, M; Moura, S; Nery, SV; Pedro, JM; Sousa, CP, 2020) |
| "The prevalence of lymphatic filariasis in adults above 18 years was 42." | 1.43 | Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania. ( Clowes, P; Haule, A; Hoelscher, M; Hoerauf, A; Kowuor, D; Kroidl, I; Löscher, T; Maboko, L; Mabuye, J; Maganga, L; Makunde, WH; Malecela, MN; Mgeni, N; Mviombo, P; Mwingira, U; Pitter, B; Saathof, E, 2016) |
| "Live weight gain was significantly lower in INF-UT (27 g/d) and INF-TT (55 g/d) than UINF-UT (88 g/d) or UINF-TT (81 g/d) treatments." | 1.38 | No loss of production due to larval challenge in sheep given continuous anthelmintic treatment via a controlled release capsule. ( Kahn, LP; Kelly, GA; Walkden-Brown, SW, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (75.00) | 24.3611 |
| 2020's | 4 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, CA | 1 |
| Krause, L | 1 |
| McManus, DP | 1 |
| Morrison, M | 1 |
| Weerakoon, KG | 1 |
| Connor, MC | 1 |
| Olveda, RM | 1 |
| Ross, AG | 1 |
| Gobert, GN | 1 |
| Lemos, M | 1 |
| Pedro, JM | 1 |
| Fançony, C | 1 |
| Moura, S | 1 |
| Brito, M | 1 |
| Nery, SV | 1 |
| Sousa, CP | 1 |
| Barros, H | 1 |
| Aboksari, MS | 1 |
| Safavi, M | 1 |
| Yoshida, H | 1 |
| Groth, C | 1 |
| Fontana, L | 1 |
| Noelck, N | 1 |
| Sikka, MK | 1 |
| Krücken, J | 1 |
| Fraundorfer, K | 1 |
| Mugisha, JC | 1 |
| Ramünke, S | 1 |
| Sifft, KC | 1 |
| Geus, D | 1 |
| Habarugira, F | 1 |
| Ndoli, J | 1 |
| Sendegeya, A | 1 |
| Mukampunga, C | 1 |
| Bayingana, C | 1 |
| Aebischer, T | 1 |
| Demeler, J | 1 |
| Gahutu, JB | 1 |
| Mockenhaupt, FP | 1 |
| von Samson-Himmelstjerna, G | 1 |
| Coulibaly, YI | 1 |
| Dicko, I | 1 |
| Keita, M | 1 |
| Keita, MM | 1 |
| Doumbia, M | 1 |
| Daou, A | 1 |
| Haidara, FC | 1 |
| Sankare, MH | 1 |
| Horton, J | 1 |
| Whately-Smith, C | 1 |
| Sow, SO | 1 |
| de Almeida, FB | 1 |
| Corrêa, CL | 1 |
| de Siqueira, NG | 1 |
| de Carvalho, NV | 1 |
| Rodrigues-Silva, R | 1 |
| de Andrade, AF | 1 |
| Machado-Silva, JR | 1 |
| Talaat, KR | 1 |
| Babu, S | 1 |
| Menon, P | 1 |
| Kumarasamy, N | 1 |
| Sharma, J | 1 |
| Arumugam, J | 1 |
| Dhakshinamurthy, K | 1 |
| Srinivasan, R | 1 |
| Poongulali, S | 1 |
| Gu, W | 1 |
| Fay, MP | 1 |
| Swaminathan, S | 1 |
| Nutman, TB | 1 |
| Mulu, A | 1 |
| Anagaw, B | 1 |
| Gelaw, A | 1 |
| Ota, F | 1 |
| Kassu, A | 1 |
| Yifru, S | 1 |
| Aliyali, M | 1 |
| Badali, H | 1 |
| Shokohi, T | 1 |
| Moazeni, M | 1 |
| Nosrati, A | 1 |
| Godazandeh, G | 1 |
| Dolatabadi, S | 1 |
| Nabili, M | 1 |
| Njaanake, KH | 1 |
| Vennervald, BJ | 1 |
| Simonsen, PE | 1 |
| Madsen, H | 1 |
| Mukoko, DA | 1 |
| Kimani, G | 1 |
| Jaoko, WG | 1 |
| Estambale, BB | 1 |
| Kroidl, I | 1 |
| Saathof, E | 1 |
| Maganga, L | 1 |
| Clowes, P | 1 |
| Maboko, L | 1 |
| Hoerauf, A | 1 |
| Makunde, WH | 1 |
| Haule, A | 1 |
| Mviombo, P | 1 |
| Pitter, B | 1 |
| Mgeni, N | 1 |
| Mabuye, J | 1 |
| Kowuor, D | 1 |
| Mwingira, U | 1 |
| Malecela, MN | 1 |
| Löscher, T | 1 |
| Hoelscher, M | 1 |
| Choksi, TT | 1 |
| Madison, G | 1 |
| Dar, T | 1 |
| Asif, M | 1 |
| Fleming, K | 1 |
| Clarke, L | 1 |
| Danilewitz, M | 1 |
| Hennawy, R | 1 |
| Patel, J | 1 |
| Ali, M | 1 |
| Kelly, GA | 1 |
| Walkden-Brown, SW | 1 |
| Kahn, LP | 1 |
| Pinot de Moira, A | 1 |
| Jones, FM | 1 |
| Wilson, S | 1 |
| Tukahebwa, E | 1 |
| Fitzsimmons, CM | 1 |
| Mwatha, JK | 1 |
| Bethony, JM | 1 |
| Kabatereine, NB | 1 |
| Dunne, DW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| AZIVAL 2: A Double-blind Cluster-randomized Placebo-controlled Study on the Safety of Integrated Treatment of Trachoma and Lymphatic Filariasis in Children and Adults With Azithromycin, Ivermectin and Albendazole[NCT01903057] | Phase 4 | 0 participants (Actual) | Interventional | 2014-02-28 | Withdrawn (stopped due to As of November 2013, the security situation in rural Northern Mozambique is no longer suitable for this clinical trial.) | ||
| A Pharmacovigilance Study on the Safety of Integrated Treatment of Trachoma and Lymphatic Filariasis in Children and Adults Living in the Sikasso Region of Mali[NCT01586169] | 3,000 participants (Actual) | Interventional | 2010-02-28 | Completed | |||
| Changes in HIV Viral Load in Patients Undergoing Treatment for Filarial Infection[NCT00344279] | 1,000 participants (Anticipated) | Observational | 2005-08-08 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for albendazole and Co-infection
| Article | Year |
|---|---|
Coinfection of Pulmonary Hydatid Cyst and Aspergilloma: Case Report and Systematic Review.
Topics: Adult; Albendazole; Animals; Anthelmintics; Antifungal Agents; Aspergillus niger; Coinfection; Echin | 2016 |
1 trial available for albendazole and Co-infection
| Article | Year |
|---|---|
A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Anti-Bacterial Agents; Azithromycin; Chemopreve | 2013 |
A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Anti-Bacterial Agents; Azithromycin; Chemopreve | 2013 |
A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Anti-Bacterial Agents; Azithromycin; Chemopreve | 2013 |
A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Anti-Bacterial Agents; Azithromycin; Chemopreve | 2013 |
14 other studies available for albendazole and Co-infection
| Article | Year |
|---|---|
Helminths, polyparasitism, and the gut microbiome in the Philippines.
Topics: Adolescent; Adult; Albendazole; Ancylostoma; Ancylostomatoidea; Animals; Ascaris; Bacteria; Child; C | 2020 |
Schistosomiasis and soil-transmitted helminthiasis preventive chemotherapy: Adverse events in children from 2 to 15 years in Bengo province, Angola.
Topics: Adolescent; Albendazole; Angola; Animals; Anthelmintics; Child; Child, Preschool; Coinfection; Feces | 2020 |
Concomitant Pulmonary Cystic Echinococcosis and Aspergillosis in a Male Child.
Topics: Albendazole; Anthelmintics; Antifungal Agents; Chest Pain; Child; Coinfection; Echinococcosis, Pulmo | 2020 |
Chest Pain and Eosinophilia in a Returning Traveler.
Topics: Adult; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Antibodies, Protozoan; Camping; Ca | 2021 |
Reduced efficacy of albendazole against Ascaris lumbricoides in Rwandan schoolchildren.
Topics: Albendazole; Animals; Anthelmintics; Ascariasis; Ascaris lumbricoides; Bayes Theorem; Benzimidazoles | 2017 |
Histopathological findings of an uncommon co-infection: Echinococcus vogeli, HIV, hepatitis C virus, and hepatitis B virus.
Topics: Albendazole; Anti-HIV Agents; Anticestodal Agents; Antiretroviral Therapy, Highly Active; Coinfectio | 2013 |
Treatment of W. bancrofti (Wb) in HIV/Wb coinfections in South India.
Topics: Adult; Albendazole; Animals; Case-Control Studies; CD4 Lymphocyte Count; Coinfection; Diethylcarbama | 2015 |
Effect of deworming on Th2 immune response during HIV-helminths co-infection.
Topics: Adult; Albendazole; Animals; Anthelmintics; Case-Control Studies; CD4-Positive T-Lymphocytes; CD8-Po | 2015 |
Schistosoma haematobium and soil-transmitted Helminths in Tana Delta District of Kenya: infection and morbidity patterns in primary schoolchildren from two isolated villages.
Topics: Albendazole; Ancylostomatoidea; Anemia; Animals; Anthelmintics; Ascaris lumbricoides; Child; Child, | 2016 |
Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
Topics: Albendazole; Animals; Antigens, Protozoan; Coinfection; Elephantiasis, Filarial; Filaricides; HIV In | 2016 |
Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment.
Topics: Albendazole; Animals; Antiparasitic Agents; Coinfection; Enterocolitis, Pseudomembranous; Gram-Negat | 2016 |
Hydatid cyst: hepatitis B and D coinfection accelerating the course of the disease.
Topics: Adult; Albendazole; Anthelmintics; Bile Ducts, Intrahepatic; Cholangitis; Coinfection; Disease Progr | 2017 |
No loss of production due to larval challenge in sheep given continuous anthelmintic treatment via a controlled release capsule.
Topics: Albendazole; Animals; Antibodies, Helminth; Antinematodal Agents; Coinfection; Delayed-Action Prepar | 2012 |
Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections.
Topics: Adolescent; Albendazole; Allergens; Ancylostomatoidea; Animals; Antibodies, Helminth; Antigens, Helm | 2013 |